Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $1.526B (100.0% shares, 0.0% debt)

Holdings (30)

— SPRINGWORKS THERAPEUTICS INC 31.5%

Value $481M Shares 5,831,307 Est. Cost $21.68 Unrealized —

AVIR ATEA PHARMACEUTICALS, INC. 7.9%

Value $121M Shares 5,615,659 Est. Cost $32.23 Unrealized -6.8%

— DYNAVAX TECHNOLOGIES CORP 7.6%

Value $116M Shares 11,771,708 Est. Cost $9.83 Unrealized —

— DICERNA PHARMACEUTICALS INC 7.5%

Value $115M Shares 3,080,237 Est. Cost $9.03 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC. 7.1%

Value $109M Shares 3,979,292 Est. Cost $26.87 Unrealized +4.8%

ANNX ANNEXON INC 4.8%

Value $72.97M Shares 3,241,628 Est. Cost $23.46 Unrealized -5.6%

CCCC C4 THERAPEUTICS, INC. 4.1%

Value $62.14M Shares 1,642,209 Est. Cost $29.00 Unrealized +23.5%

PHVS PHARVARIS N.V. 3.9%

Value $59.26M Shares 3,180,601 Est. Cost $31.46 Unrealized -27.9%

— MERSANA THERAPEUTICS INC. 3.3%

Value $50.19M Shares 3,695,667 Est. Cost $22.91 Unrealized —

NRIX NURIX THERAPEUTICS INC 2.2%

Value $34.07M Shares 1,284,314 Est. Cost $25.20 Unrealized +16.5%

CRNX CRINETICS PHARMACEUTICALS 2.1%

Value $31.66M Shares 1,679,701 Est. Cost $17.24 Unrealized +1.9%

— SYROS PHARMACEUTICALS INC. 2.1%

Value $31.53M Shares 5,785,036 Est. Cost $10.85 Unrealized —

— SOLID BIOSCIENCES INC 1.9%

Value $29.02M Shares 7,929,918 Est. Cost $7.99 Unrealized —

— MARINUS PHARMACEUTICALS INC 1.7%

Value $25.67M Shares 1,431,058 Est. Cost $15.48 Unrealized —

— APTINYX INC 1.6%

Value $25.16M Shares 8,891,758 Est. Cost $8.16 Unrealized —

KYMR KYMERA THERAPEUTICS INC. 1.5%

Value $23.26M Shares 479,605 Est. Cost $30.53 Unrealized +42.2%

NAUT NAUTILUS BIOTECHNOLOGY INC. 1.3%

Value $20.2M Shares 2,000,000 Est. Cost $10.83 Unrealized 0.0%

SVRA SAVARA INC 1.3%

Value $19.76M Shares 11,622,598 Est. Cost $1.49 Unrealized +20.9%

— AEGLEA BIO THERAPEUTICS INC 1.2%

Value $18.79M Shares 2,700,000 Est. Cost $9.25 Unrealized —

— BLUEBIRD BIO, INC. 1.1%

Value $17.21M Shares 538,179 Est. Cost $30.15 Unrealized —

— X4 PHARMACEUTICALS INC 0.9%

Value $13.78M Shares 2,119,540 Est. Cost $10.24 Unrealized —

— BCTG ACQUISITION CORP 0.7%

Value $10.49M Shares 921,790 Est. Cost $10.83 Unrealized —

— RESEARCH ALLIANCE CORP II 0.7%

Value $10.14M Shares 1,000,000 Est. Cost $10.25 Unrealized —

— ARYA SCIENCES ACQU CORP IV 0.5%

Value $7.504M Shares 700,000 Est. Cost $10.47 Unrealized —

— BCLS ACQUISITION CORP 0.3%

Value $5.133M Shares 487,500 Est. Cost $11.14 Unrealized —

— PANACEA ACQUISITION CORP II 0.3%

Value $5.01M Shares 500,000 Est. Cost $10.02 Unrealized —

— OMEGA ALPHA SPAC 0.3%

Value $3.98M Shares 400,000 Est. Cost $9.90 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.2%

Value $3.015M Shares 300,000 Est. Cost $10.38 Unrealized —

— JIYA ACQUISITION CORP 0.2%

Value $2.982M Shares 300,000 Est. Cost $10.30 Unrealized —

MLTX HELIX ACQUISITION CORP 0.2%

Value $2.588M Shares 250,000 Est. Cost $11.37 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	5,831,307	$481M	31.5%	$21.68	—	COM	85205L107
AVIR	ATEA PHARMACEUTICALS, INC.	5,615,659	$121M	7.9%	$32.23	-6.8%	COM	04683R106
—	DYNAVAX TECHNOLOGIES CORP	11,771,708	$116M	7.6%	$9.83	—	COM	268158201
—	DICERNA PHARMACEUTICALS INC	3,080,237	$115M	7.5%	$9.03	—	COM	253031108
ARQT	ARCUTIS BIOTHERAPEUTICS INC.	3,979,292	$109M	7.1%	$26.87	+4.8%	COM	03969K108
ANNX	ANNEXON INC	3,241,628	$72.97M	4.8%	$23.46	-5.6%	COM	03589W102
CCCC	C4 THERAPEUTICS, INC.	1,642,209	$62.14M	4.1%	$29.00	+23.5%	COM STK	12529R107
PHVS	PHARVARIS N.V.	3,180,601	$59.26M	3.9%	$31.46	-27.9%	COM	N69605108
—	MERSANA THERAPEUTICS INC.	3,695,667	$50.19M	3.3%	$22.91	—	COM	59045L106
NRIX	NURIX THERAPEUTICS INC	1,284,314	$34.07M	2.2%	$25.20	+16.5%	COM	67080M103
CRNX	CRINETICS PHARMACEUTICALS	1,679,701	$31.66M	2.1%	$17.24	+1.9%	COM	22663K107
—	SYROS PHARMACEUTICALS INC.	5,785,036	$31.53M	2.1%	$10.85	—	COM	87184Q107
—	SOLID BIOSCIENCES INC	7,929,918	$29.02M	1.9%	$7.99	—	COM	83422E105
—	MARINUS PHARMACEUTICALS INC	1,431,058	$25.67M	1.7%	$15.48	—	COM	56854Q200
—	APTINYX INC	8,891,758	$25.16M	1.6%	$8.16	—	COM	03836N103
KYMR	KYMERA THERAPEUTICS INC.	479,605	$23.26M	1.5%	$30.53	+42.2%	COM	501575104
NAUT	NAUTILUS BIOTECHNOLOGY INC.	2,000,000	$20.2M	1.3%	$10.83	0.0%	COM	63909J108
SVRA	SAVARA INC	11,622,598	$19.76M	1.3%	$1.49	+20.9%	COM	805111101
—	AEGLEA BIO THERAPEUTICS INC	2,700,000	$18.79M	1.2%	$9.25	—	COM	00773J103
—	BLUEBIRD BIO, INC.	538,179	$17.21M	1.1%	$30.15	—	COM	09609G100
—	X4 PHARMACEUTICALS INC	2,119,540	$13.78M	0.9%	$10.24	—	COM	98420X103
—	BCTG ACQUISITION CORP	921,790	$10.49M	0.7%	$10.83	—	COM	05492W103
—	RESEARCH ALLIANCE CORP II	1,000,000	$10.14M	0.7%	$10.25	—	COM CL A	760873109
—	ARYA SCIENCES ACQU CORP IV	700,000	$7.504M	0.5%	$10.47	—	CL A	G31659108
—	BCLS ACQUISITION CORP	487,500	$5.133M	0.3%	$11.14	—	COM CL A	G0904B105
—	PANACEA ACQUISITION CORP II	500,000	$5.01M	0.3%	$10.02	—	CL A SHS	G6882C106
—	OMEGA ALPHA SPAC	400,000	$3.98M	0.3%	$9.90	—	CL A	G6749V107
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$3.015M	0.2%	$10.38	—	UNIT 12/09/2025	G3710A121
—	JIYA ACQUISITION CORP	300,000	$2.982M	0.2%	$10.30	—	COM CL A	47760M102
MLTX	HELIX ACQUISITION CORP	250,000	$2.588M	0.2%	$11.37	—	COM CL A	G4444C102